Earnouts v2 Know when to use Earnouts to reduce risk, break a negotiation deadlock and get it done. Negotiation Whitepapers methodology
Demystifying M&A Valuation Chinese 估值是每笔交易中最关键的部分,但它往往是最不被理解的部分。与Ascento Capital的管理合伙人本·博伊塞万(Ben Boissevain)一起探讨估值的细微差别、估值框架以及正确估值的流程。 Mergers & Acquisitions Valuation Whitepapers
Demystifying Tech M&A Valuation korean 가치 평가는 모든 거래에서 가장 중요한 부분이지만 중요한 만큼 이해가 어려운 분야입니다. 아센토 캐피털의 매니징 파트너인 벤 보이세빈 (Ben Boissevain)과 함께 "가치 평가"라는 단어의 의미, 개요 및 가치 평가를 성공적으로 처리하기 위한 과정을 알아보십시오. Technology Valuation Whitepapers
Capital Raising Term Sheet Get the strategies and insights to create a realistic term sheet that everyone can agree to. Fundraising Negotiation Webinars
Negotiating Working Capital Working capital can be difficult to understand and is one of the most conflicting issues in M&A negotiations and valuation. Mergers & Acquisitions Negotiation Webinars
Due Diligence Checklist This all-purpose due diligence checklist contains a list of all the standard documents any buyer or partner might want to see. . BioPharma Due Diligence Due Diligence Checklists Energy Finance Fundraising Legal Life Sciences Mergers & Acquisitions Other Industries Other Topics Real Estate Top Content
Eight Habits of Highly Effective Data Rooms In this whitepaper, you will learn 8 "habits" of highly effective data rooms to ensure your selection facilitates the due diligence process rather than impede it. Best Practices & Trends Energy Finance Legal Life Sciences Other Industries Real Estate Top Content Virtual Data Room Whitepapers
Essential Steps to Successful Biopharma Partnering This whitepaper provides a strategic perspective coupled with actionable tips to help guide you through the essential steps that will help maximize your chance of achieving success in biopharma partnering. BioPharma Licensing & Partnering Life Sciences Whitepapers
Valuation of Your Early Drug Candidate In this whitepaper, author Linda Pullan reviews the different techniques, key variables, and characteristics of what makes a drug candidate more valuable to a partner. Life Sciences Series Valuation Whitepapers
Getting Ready for a Biopharma Partnering Deal This whitepaper provides actionable advice for Biotech business development leaders on how to get ready for a partnering deal. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers
Must-Know Finance Concepts for Life Sciences Valuations - Part II This whitepaper discusses which asset valuation methodology is most used by big pharma to evaluate possible partners or acquisitions and an explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital, and present value. Best Practices & Trends BioPharma Life Sciences Valuation Whitepapers
Demystifying Tech M&A Valuation In this whitepaper, explore the nuances of valuation, its framework and the processes for getting it right. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Valuation Whitepapers